178436-06-1 ((Ceramide 3)

ceramide np;N-oleoylphytosphingosine;N-oloeoyl-4-hydroxysphinganine;Ceramide 3;N-(9Z-octadecenoyl)phytosphingosine;Cer(t18:0/18:1n-9);4370DF050B;Ceramide IIIB;Cytomide IIIa;Cytomide IIIb;Ceramide GL(3);N-oleoyl phytosphingosine;N-oleoyl-phytosphingosine;PHCer C18:1(n-9);DB14111;N-(9Z-octadecenoyl)-4-hydroxysphinganine;N-(9Z-octadecenoyl)-(4R)-hydroxysphinganine;Burkitt's Lymphoma associated glycolipid antigen;(2S,3S,4R)-2-(Oleoylamino)-1,3,4-octadecan;ViableCare Ceramide NP;

ATGQXSBKTQANOH-UWVGARPKSA-N

1S/C36H71NO4/c1-3-5-7-9-11-13-15-17-18-19-21-23-25-27-29-31-35(40)37-33(32-38)36(41)34(39)30-28-26-24-22-20-16-14-12-10-8-6-4-2/h17-18,33-34,36,38-39,41H,3-16,19-32H2,1-2H3,(H,37,40)/b18-17-/t33-,34+,36-/m0/s1

O[C@@H]([C@H]([C@H](CO)NC(CCCCCCC/C=C\CCCCCCCC)=O)O)CCCCCCCCCCCCCC

309-560-3